Ischemic strokes related to atrial fibrillation are highly prevalent, presenting with severe
neurologic syndromes and associated with high risk of recurrence. Although advances have …

Objective: To compare the neuroimaging profile and clinical outcomes among patients with
intracerebral hemorrhage (ICH) related to use of vitamin K antagonists (VKAs) or direct oral …

Objective It is not known whether patients with atrial fibrillation (AF) with ischemic stroke
despite oral anticoagulant therapy are at increased risk for further recurrent strokes or how …

Background and Purpose—Despite treatment with oral anticoagulants, patients with
nonvalvular atrial fibrillation (AF) may experience ischemic cerebrovascular events. The …

Atherosclerosis is a major cause of ischemic stroke that can be effectively prevented with
appropriate lifestyle modifications and control of cardiovascular risk factors. Medical …

Abstract Background Direct oral anticoagulants (DOACs) are indicated for the prevention of
stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation. While no …

Background and purpose Intracranial hemorrhage (ICH) is the most feared complication in
patients treated with oral anticoagulants due to non‐valvular atrial fibrillation. Non‐vitamin K …

Essentials• Risk of intracranial hemorrhage (ICH) may differ between direct oral
anticoagulants (DOACs).• We compared the risk of ICH between DOACs using network meta …

Cerebrovascular disease is a major cause of morbidity, mortality, and disability in women.
The spectrum of disease differs between men and women, with women being particularly …

In 2014, the definition of embolic strokes of undetermined source (ESUS) emerged as a new
clinical construct to characterize cryptogenic stroke (CS) patients with complete vascular …